Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients

by

Bengaluru: Drugmaker Sun Pharmaceutical Industries Ltd said on Friday that it received Indian regulatory approval to start clinical trials of pancreatitis drug nafamostat mesilate in COVID-19 patients.

"Nafamostat (has been) identified as a potential candidate for COVID-19 patients by scientists at University of Tokyo and Leibniz Institute for Primate Research, Germany," the company said in a statement.

Click here to follow LIVE updates on coronavirus outbreak

The University of Tokyo had announced plans for a trial of nafamostat and camostat mesilate, a related drug, starting as early as April 2020.

Shares of Sun Pharma rose 5 percent intraday on Friday after receiving approval from the Indian drug regulator for clinical trial of its drug on COVID-19 patients.

Also See

Sun Pharma Q4 results: Consolidated net profit declines 37% to Rs 399 cr; revenue up 14% to Rs 8,185 crPharma major Sun Pharmaceutical Industries on Wednesday reported a 37.12 percent decline in its consolidated net profit to Rs 399.84 crore for the quarter ended March 2020, mainly on account of one time exceptional lossPress Trust of India, 27 May 2020Sun Pharma, SPARC ink pact for potential treatment for atopic dermatitis, auto-immune disordersSun Pharmaceutical Industries Ltd and Sun Pharma Advanced Research Company (SPARC) on Thursday said they have entered into a worldwide licensing pact for development and commercialisation of a novel molecule which can be used for the potential treatment of atopic dermatitis, psoriasis and other auto-immune disordersPress Trust of India, 28 May 2020Coronavirus Outbreak: Baseball players respond to MLB on virus protocols, demand more testingPlayers viewed many of the concepts in the original draft as over-the-top, such as arriving in uniform at the ballparks, a prohibition on them leaving without team permission, and a ban on guests other than immediate family members.The Associated Press, 22 May 2020https://www.firstpost.com/india/coronavirus-outbreak-7000-beds-to-be-added-in-mumbai-hospitals-over-next-14-days-to-treat-covid-19-patients-8409261.html